Appili Therapeutics Inc (APLI : TSX)
Common Stock
$0.01
CAD
-0.01 (-50.00%)
Last updated: 2026-10-02
Follow APLI
APLI
Appili Therapeutics Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-80.00%
Key Statistics
Market Cap
$661,830
52W High
$0.03
52W Low
$0.01
P/E Ratio
-
50 Day MA
$0.01
200 Day MA
$0.02
Beta
-0.19
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/2/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 117,001 |
| 9/29/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 969,152 |
| 9/25/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 2,900 |
| 9/23/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 250,000 |
| 9/22/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 47,519 |
| 9/21/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 99,266 |
| 9/18/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 1,000 |
| 9/17/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 77,000 |
| 9/16/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 339,000 |
| 9/15/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 2,000 |
Analyst Price Targets
Based on analyst covering APLI · as of Sep 17, 2026
Wall Street analysts forecast APLI stock price to rise 2900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+2900.0% Upside
Current Price
C$0.01
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
473.3%
Annualized
90-Day Vol
313.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.00 | C$0.00 – C$0.02 |
| 60 trading days | C$0.00 | C$0.00 – C$0.04 |
| 90 trading days | C$0.00 | C$0.00 – C$0.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Appili Therapeutics Inc
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections. It also develops ATI-1801, a topical formulation of paromomycin in a Phase III trial for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine in preclinical trials for the prevention of Francisella tularensis infection. The company has a collaboration with Vitalex Biosciences to advance VXV-01, a dual-antigen vaccine targeting invasive Candida infections. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Financials
- Revenue (TTM)
- $362,073
- EBITDA
- $-6.53M
- Profit Margin
- 0.00%
- ROE (TTM)
- -938.72%
- EPS (Diluted)
- -0.03
- Book Value
- -0.14
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About APLI
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AAB | Aberdeen International Inc. | $0.02 | +33.33% |
| XMF-A | M Split Corp | $1.99 | +17.06% |
| CNT | Century Global Commodities Corp | $0.04 | +16.67% |
| LABS | Medipharm Labs Corp | $0.07 | +16.67% |
| HSTR | Heliostar Metals Ltd. | $2.24 | +15.46% |
| DSV | Discovery Silver Corp. | $11.09 | +15.28% |
| PRL | Propel Holdings Inc | $30.53 | +15.16% |
| HMM-A | Hammond Manufacturing Company Limited | $30.00 | +15.03% |
APLI.TO news timeline
15 articles covering APLI.TO, most recent first
LatestWhy Appili Therapeutics Inc stock surged yesterday
September 2026
- Why Appili Therapeutics Inc stock plummeted yesterday
- Why Appili Therapeutics Inc stock surged yesterday
- Why Appili Therapeutics Inc stock is skyrocketing today
- Why Appili Therapeutics Inc stock plummeted yesterday
- Why Appili Therapeutics Inc stock surged yesterday
- What's Going On With Appili Therapeutics Inc Stock Monday?
- What's Going On With Appili Therapeutics Inc Stock Friday?
- Why Appili Therapeutics Inc stock plummeted yesterday
August 2026
- What's Going On With Appili Therapeutics Inc Stock Monday?
- Why Appili Therapeutics Inc stock surged yesterday
- Why Appili Therapeutics Inc stock plummeted yesterday
- What's Going On With Appili Therapeutics Inc Stock Monday?
- Why Appili Therapeutics Inc stock surged yesterday
- Why Appili Therapeutics Inc stock is skyrocketing today